Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines
- PMID: 12642092
- DOI: 10.1016/s0042-6822(02)00041-7
Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines
Abstract
Steroid hormone receptors have been shown to bind to response elements in the upstream regulatory region (URR) of human papillomavirus (HPV) in a ligand-dependent manner to affect viral promoter activity. To better understand how the enhancer activity of the URR differs between high risk HPV types, we chose to compare the basal and glucocorticoid-dependent activities of the URRs of HPV18 and HPV31. We found that the URR of HPV18 is a stronger enhancer than the URR of HPV31 in six different cell lines of epithelial origin. Furthermore, the activity of the URR of HPV31 was not inducible by the synthetic glucocorticoid dexamethasone (dex) in any cell line tested, while the URR of HPV18 was dex-inducible in the majority of these lines. These studies indicate significant differences between the URRs of high risk HPV types.
Similar articles
-
The upstream regulatory region of human papillomavirus type 31 is insensitive to glucocorticoid induction.J Virol. 2002 Oct;76(19):9702-15. doi: 10.1128/jvi.76.19.9702-9715.2002. J Virol. 2002. PMID: 12208949 Free PMC article.
-
Induction of the upstream regulatory region of human papillomavirus type 31 by dexamethasone is differentiation dependent.J Virol. 2003 Oct;77(20):10975-83. doi: 10.1128/jvi.77.20.10975-10983.2003. J Virol. 2003. PMID: 14512546 Free PMC article.
-
Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.J Virol. 1993 Nov;67(11):6476-86. doi: 10.1128/JVI.67.11.6476-6486.1993. J Virol. 1993. PMID: 8411351 Free PMC article.
-
The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones.EMBO J. 1987 Dec 1;6(12):3735-43. doi: 10.1002/j.1460-2075.1987.tb02708.x. EMBO J. 1987. PMID: 2828035 Free PMC article.
-
Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprinting.J Virol. 1998 Jan;72(1):708-16. doi: 10.1128/JVI.72.1.708-716.1998. J Virol. 1998. PMID: 9420277 Free PMC article.
Cited by
-
Human Papilloma Virus Identification in Breast Cancer Patients with Previous Cervical Neoplasia.Front Oncol. 2016 Jan 8;5:298. doi: 10.3389/fonc.2015.00298. eCollection 2015. Front Oncol. 2016. PMID: 26779441 Free PMC article.
-
Naturally Occurring Variations Modulate the Activity of the HPV33 Early Promoter and its Affinity for the E2 Transcription Factor.Sci Rep. 2018 Oct 9;8(1):15015. doi: 10.1038/s41598-018-33243-y. Sci Rep. 2018. PMID: 30301935 Free PMC article.
-
Detection of human papillomavirus-16 DNA in archived clinical samples of breast and lung cancer patients from North Pakistan.J Cancer Res Clin Oncol. 2016 Dec;142(12):2497-2502. doi: 10.1007/s00432-016-2251-z. Epub 2016 Sep 9. J Cancer Res Clin Oncol. 2016. PMID: 27613186 Free PMC article.
-
The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics.Cells. 2022 Aug 15;11(16):2528. doi: 10.3390/cells11162528. Cells. 2022. PMID: 36010605 Free PMC article. Review.
-
Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter.J Virol. 2005 Mar;79(6):3309-21. doi: 10.1128/JVI.79.6.3309-3321.2005. J Virol. 2005. PMID: 15731225 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical